News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Akhil Santhosh: The 3-year results of RELATIVITY 047 out in Journal of Clinical Oncology
everydayhealth.com
Dec 17, 2024, 01:39

Akhil Santhosh: The 3-year results of RELATIVITY 047 out in Journal of Clinical Oncology

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X about a recent paper by Hussein Tawbi et al. published in JCO:

“The 3-year results of RELATIVITY 047 out in Journal of Clinical Oncology.

Nivolumab and relatlimab continues to impress. Toxicity profile better than nivo ipi. Interestingly, at the 3 year follow up, upper bound of HR 95% ci is less than 1 for overall survival.”

“Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047”

Authors: Hussein Tawbi et al.

Akhil Santhosh: The 3-year results of RELATIVITY 047 out in Journal of Clinical Oncology

More posts featuring Akhil Santhosh.

Akhil Santhosh ASCO cancer Hussein Tawbi Journal of Clinical Oncology OncoDaily Oncology RELATIVITY-047
Special Coverage
Blog
Jan 15, 2025, 08:23
Pashtoon Kasi: Different kind of liquid biopsies in guiding care of patients with cancer
Blog
Jan 15, 2025, 08:14
Chokri Ben Lamine: Immune Targets in Hematologic Malignancies
Blog
Jan 15, 2025, 08:06
Shushan Hovsepyan: 20 million participants at the first-ever 2025 CACA-OncoDaily-SPCC Cancer Summit
Opinion
Jan 15, 2025, 07:58
The Power of Equity: Funding Research to Close Gaps in Colorectal Cancer Outcomes
Blog
Jan 15, 2025, 07:53
Moses Echodu: Recounting 2024 and Looking at 2025 - Growth and Acceleration
Blog
Jan 15, 2025, 07:49
Breaking Ground in Genomics: India Launches "Genome India" Database - Canary Oncoceutics
Science
Jan 15, 2025, 07:40
Anirban Maitra: The impact of KRAS allelic status on outcomes in Pancreatic Cancer
Science
Jan 15, 2025, 07:31
Melvin LK Chua: Chromatin-related adaptation for acquired Radioresistance in Head and Neck Cancer
Blog
Jan 15, 2025, 07:27
Akhil Santhosh: I am among the recipients of the ASCO IDEA award 2025
Societies
Jan 15, 2025, 07:22
Benjamin Ebert: Excited to launch the Center for RAS Therapeutics
Science
Jan 15, 2025, 07:07
Samuel Hume: Top 5 advances in medicine this week
Blog
Jan 15, 2025, 06:56
KCRS25 is coming to Boston - KidneyCAN